首页 | 官方网站   微博 | 高级检索  
     


The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States
Authors:Mariantonia Ferrara  Laura Eggenschwiler  Andrew Stephenson  Alyssa Montieth  Nakhoul Nakhoul  Rafael Araùjo-Miranda
Affiliation:1. Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA;2. The Ocular Immunology and Uveitis Foundation, Waltham, Massachusetts, USA;3. Department of Neuroscience, Reproductive and Odontostomatological Science, Federico II University, Naples, Italy;4. Department of Ophthalmology, Barich Padeh Medical Center, Poriya, Israel;5. Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel;6. FISABIO Oftalmologia Medica, Valencia, Spain
Abstract:Purpose: To describe the distribution, clinical findings, visual outcomes, treatment, and complications of children with uveitis at a tertiary referral ophthalmic center.

Methods: Retrospective cohort study. We reviewed the medical records of all patients ≤16 years with uveitis referred to Massachusetts Eye Research and Surgery Institution from March 2005 to July 2016.

Results: Of 286 included children, 62.24% were female. Mean age of onset was 8.4 years. The uveitis was mainly anterior (61.9%), recurrent (68.53%), bilateral (81.82%), and noninfectious (96.5%). Idiopathic cases accounted for 51.4%. The most frequent systemic association was juvenile idiopathic arthritis (34.96%). The majority of patients (78.32%) experienced complications. All patients, except one, needed systemic therapy.

Conclusion: Pediatric uveitis is challenging to diagnose and manage, with frequent and potentially severe complications. Most cases were bilateral, recurrent, and idiopathic. Prompt referral to uveitis-specialized centers and an appropriate systemic therapy are mandatory for good visual outcomes.

Keywords:Epidemiology  immunomodulatory therapy  pediatric uveitis  uveitis  visual loss
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号